Common Contracts

AGREEMENT AND PLAN OF MERGER among ELI LILLY AND COMPANY, TYTO ACQUISITION CORPORATION, and PREVAIL THERAPEUTICS INC. Dated as of December 14, 2020

Agreement and Plan of Merger • December 15th, 2020 • Prevail Therapeutics Inc. • Biological products, (no disgnostic substances) • Delaware

• Contract Type
  Agreement and Plan of Merger
• Filed
  December 15th, 2020
• Company
  Prevail Therapeutics Inc.
• Industry
  Biological products, (no disgnostic substances)
• Jurisdiction
  Delaware

AGREEMENT AND PLAN OF MERGER, dated as of December 14, 2020 (this “Agreement”), among Eli Lilly and Company, an Indiana corporation (“Parent”), Tyto Acquisition Corporation, a Delaware corporation and wholly owned Subsidiary of Parent (“Purchaser”), and Prevail Therapeutics Inc., a Delaware corporation (the “Company”).